Boston Scientific BSX is slated to report fourth-quarter fiscal 2024 results on Feb. 5 before market open. See the Zacks Earnings Calendar to stay ahead of market-making news. For fourth-quarter ...

We recently compiled a list of the 12 Best Fundamental Stocks to Buy Now. In this article, we are going to take a look at ...

The company’s third-quarter earnings report for fiscal 2024 showed strong sales growth and adjusted per-share earnings of ...

Boston Scientific Corp. engages in the development ... The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral ...

Disclosure: David Carr-Locke, MD, FRCP, has disclosed that he has received grants for clinical research from Boston Scientific Endoscopy, ConMed Endoscopy, Bard, Inscope, and Oridion. Dr. Carr ...

Boston Scientific closes the year at historic highs ... includes diagnostic and invasive devices in the fields of Endoscopy, Cardiology, Electrophysiology, and Neuromodulation.

The company primarily operates through its MedSurg (endoscopy, urology ... there’s a powerful fundamental story happening with Boston Scientific. Also, EPS is estimated to ramp higher this ...